| Authors: |
Tsikis ST; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts., Fligor SC; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts., Secor JD; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts., Yu LJ; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts., Pan A; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts., Loring G; Alcresta Therapeutics, Newton, Massachusetts., First E; Alcresta Therapeutics, Newton, Massachusetts., Nedder AP; Animal Care Resources Children's Hospital, Boston Children's Hospital, Boston, Massachusetts., Grammer RM; Animal Care Resources Children's Hospital, Boston Children's Hospital, Boston, Massachusetts., Rudie C; Department of Gastroenterology, Boston Children's Hospital, Boston, Massachusetts., Gura KM; Department of Pharmacy and the Division of Gastroenterology and Nutrition, Boston Children's Hospital, Boston, Massachusetts., Puder M; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: Mark.Puder@childrens.harvard.edu. |